1. Bosch, Elisabeth, Popp, Bernt, Güse, Esther, Accogli, Andrea, Vasileiou, Georgia. 2023. Elucidating the clinical and molecular spectrum of SMARCC2-associated NDD in a cohort of 65 affected individuals. In Genetics in medicine : official journal of the American College of Medical Genetics, 25, 100950. doi:10.1016/j.gim.2023.100950. https://pubmed.ncbi.nlm.nih.gov/37551667/
2. Magarifuchi, Naomi, Iwasaki, Takeshi, Katayama, Yoshihiro, Kato, Kiyoko, Oda, Yoshinao. 2024. Gene amplification of chromatin remodeling factor SMARCC2 and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma. In Oncology letters, 27, 196. doi:10.3892/ol.2024.14329. https://pubmed.ncbi.nlm.nih.gov/38516682/
3. Sun, Zhaoran, Wang, Zhongkun, Zhang, Yirao, Liu, Hao, Zhang, Daoyong. 2024. SMARCC2 silencing suppresses oncogenic activation through modulation of chromatin accessibility in breast cancer. In Biochemical and biophysical research communications, 724, 150223. doi:10.1016/j.bbrc.2024.150223. https://pubmed.ncbi.nlm.nih.gov/38852505/
4. Li, Chiyang, Wang, Tong, Gu, Junwei, Lu, Yuntao, Zhou, Qiang. 2022. SMARCC2 mediates the regulation of DKK1 by the transcription factor EGR1 through chromatin remodeling to reduce the proliferative capacity of glioblastoma. In Cell death & disease, 13, 990. doi:10.1038/s41419-022-05439-8. https://pubmed.ncbi.nlm.nih.gov/36418306/
5. Schmetz, Ariane, Lüdecke, Hermann-Josef, Surowy, Harald, Bramswig, Nuria C, Wieczorek, Dagmar. 2023. Delineation of the adult phenotype of Coffin-Siris syndrome in 35 individuals. In Human genetics, 143, 71-84. doi:10.1007/s00439-023-02622-5. https://pubmed.ncbi.nlm.nih.gov/38117302/
6. Yuan, Hao, Chen, Zhaofeng, Bai, Suyang, Zhou, Yongning, Qiao, Liang. 2018. Molecular mechanisms of lncRNA SMARCC2/miR-551b-3p/TMPRSS4 axis in gastric cancer. In Cancer letters, 418, 84-96. doi:10.1016/j.canlet.2018.01.032. https://pubmed.ncbi.nlm.nih.gov/29337109/
智鼠故事 
